Why participate?
Recognize the importance of anticipating product development and gain the tools to prepare for due diligence.
Training Context:
The technological breakthrough brought about by the rise of biotechnology has led to a profound shift in corporate strategies. In fact, the proportion of drugs developed entirely in-house has dropped from 80% in the 1970s to around 40–60% by 2024. Today, license acquisitions and transfers are not only a matter of survival for many companies — they are also a strong indicator of company health and can unlock new financial and licensing opportunities.
Experience sharing, presentations, case studies, group work, questionnaires.
Business leaders, project managers, scientific teams.
No prerequisites required
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
Participant satisfaction rate :
Return rate of satisfaction questionnaires :
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
